Schedule of outstanding warrants classified as a liability |
Outstanding |
|
|
Exercise price |
|
Issuance year |
|
Exercisable through |
|
Fair value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
120,000 |
|
|
$ |
0.92(*) |
|
2014 |
|
(*****) |
|
|
6 |
|
|
(********) |
|
296,813 |
|
|
|
1.50 |
|
2015 |
|
2020 |
|
|
- |
|
|
(********) |
|
374,001 |
|
|
|
1.50 |
|
2016 |
|
2021 |
|
|
2 |
|
|
(********) |
|
905,555 |
|
|
|
0.17 |
|
2017 |
|
2022 |
|
|
22,027 |
|
|
Refer to Note 8b |
|
333,333 |
|
|
|
1.50 |
|
2017 |
|
2022 |
|
|
96 |
|
|
Refer to Note 11b5 |
|
53,333 |
|
|
|
1.50 |
|
2017 |
|
2022 |
|
|
2 |
|
|
Refer to Note 11b1 |
|
50,000 |
|
|
|
1.50 |
|
2017 |
|
2022 |
|
|
3 |
|
|
Refer to Note 8a |
|
33,332 |
|
|
|
1.20 |
|
2017 |
|
2022 |
|
|
16 |
|
|
Refer to Note 8b |
|
33,332 |
|
|
|
1.00 |
|
2017 |
|
2022 |
|
|
16 |
|
|
Refer to Note 8b |
|
675,926 |
|
|
|
(**) |
|
2017 |
|
2022 |
|
|
68,275 |
|
|
Refer to Note 3 |
|
11,111 |
|
|
|
1.20 |
|
2017 |
|
2022 |
|
|
4 |
|
|
Refer to Note 11b7 |
|
300,000 |
|
|
|
0.50 |
|
2018 |
|
2023 |
|
|
1,560 |
|
|
Refer to Note 11b6 |
|
1,659,971 |
|
|
|
0.17 |
|
2018 |
|
2022 |
|
|
11,522 |
|
|
Refer to Note 8b |
|
29,411,765 |
|
|
|
0.17(***) |
|
2018 |
|
2021(******) |
|
|
420,386 |
|
|
Refer to Note 8e |
|
15,441,177 |
|
|
|
(****) |
|
(****) |
|
(****) |
|
|
220,704 |
|
|
Refer to Note 8e |
|
6,617,647 |
|
|
|
0.17(***) |
|
2018 |
|
2020(*******) |
|
|
50,510 |
|
|
Refer to Note 8f |
|
11,764,706 |
|
|
|
0.17(***) |
|
2018 |
|
2020(*******) |
|
|
107,602 |
|
|
Refer to Note 8g |
|
1,411,765 |
|
|
|
0.17(***) |
|
2019 |
|
2024 |
|
$ |
49,100 |
|
|
Refer to Note 8g |
|
5,882,352 |
|
|
|
0.17(***) |
|
2019 |
|
2021(*******) |
|
|
61,541 |
|
|
Refer to Note 8h |
|
18,382,352 |
|
|
|
0.17(***) |
|
2019 |
|
2021(******) |
|
|
262,742 |
|
|
Refer to Note 8e |
|
13,970,587 |
|
|
$ |
0.17(***) |
|
2019 |
|
2021(*******) |
|
|
227,998 |
|
|
Refer to Note 8i |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
107,729,058 |
|
|
|
|
|
|
|
|
$ |
1,504,112 |
|
|
(*********) |
|
(*) |
Subject to changes as describe in
the agreement. |
|
(***) |
Subject to a mechanism described
in the agreement but not less than $0.17, therefore, the outstanding amounts were calculated based on an exercise price of $0.17, which
results in the maximum potential amount of warrants. |
|
(****) |
Since the actual number of warrants
cannot be determined as of December 31, 2019, the outstanding amounts were calculated based on an exercise price of $0.17, which results
in the maximum potential amount of warrants. |
|
(*****) |
M&A or qualified PO as described
in the agreement. |
|
(******) |
Two years from the registration
statement or a PO, the earlier |
|
(*******) |
Two years or a PO, the earlier. |
|
(********) |
Issued in connection with the 2016,
2015 and 2014 financing rounds. |
|
(*********) |
Contains warrants presented at fair value within current liabilities of $158,112 and within non-current liabilities of $1,346,000. |
|